ASK PHARMA DEVELOPMENT LIMITED
B68/100Summary
ASK PHARMA DEVELOPMENT LIMITED is an active private limited company (company number 10338746) incorporated on 19 August 2016, registered in Birmingham. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2025, showing net assets of £25k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets were unchanged on the prior period.
By net assets it sits in the upper half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Key dates
- Incorporated
- 19 August 201610 yrs ago
- Next accounts due
- 31 December 2026in 70 days
- Confirmation statement due
- 2 September 2027in 315 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £25k | — | — | — | — | — | 1 |
| 31 March 2024 | £25k | — | — | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score
| 50 | Starting scoreEvery scored company starts here |
| +10 | Positive net assetsNet assets £25,171 at 2025-03-31 |
| +8 | EstablishedIncorporated 2016-08-19 (10 years) |
| 68 | Score, grade B |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
Ownership and control
- Professor Afzal Ur Rahman Mohammed
- owns 50–75% of shares
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Timeline
- Confirmation statement duein 315 days
- Next accounts duein 70 days
- Accounts period endNet assets £25k · micro accounts
- Accounts period endNet assets £25k · micro accounts
- Incorporated
Similar companies in Birmingham
- APARON LTDTamworth · inc. Nov 2016
- ACHILLES THERAPEUTICS UK LIMITEDBirmingham · inc. May 2016
- MIRZYME THERAPEUTICS LIMITEDBirmingham · inc. Apr 2016
- MRM GORE GROUP LTDBrierley Hill · inc. Jan 2017
- GIFFORD BIOSCIENCE LIMITEDSolihull · inc. Feb 2017
- ACCUNEA LTD.Kidderminster · inc. Mar 2017
All companies incorporated on 19 August 2016 · in Aug 2016.
Reminders for ASK PHARMA DEVELOPMENT LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.